In this work, the effect of two processes, i.e., freeze-drying and supercritical CO2 (SC-CO2) drying, on the final morphology of agarose-based porous structures, was investigated. The agarose concentration in water was varied from 1 wt% up to 8 wt%. Agarose cryogels were prepared by freeze-drying using two cooling rates: 2.5 °C/min and 0.1 °C/min. A more uniform macroporous structure and a decrease in average pore size were achieved when a fast cooling rate was adopted. When a slower cooling rate was performed instead, cryogels were characterized by a macroporous and heterogenous structure at all of the values of the biopolymer concentration investigated. SC-CO2 drying led to the production of aerogels characterized by a mesoporous structure, with a specific surface area up to 170 m2/g. Moreover, agarose-based aerogels were solvent-free, and no thermal changes were detected in the samples after processing.
A comparative analysis concerning bio-based gels production, to be used for tissue regeneration, has been performed in this review. These gels are generally applied as scaffolds in the biomedical field, thanks to their morphology, low cytotoxicity, and high biocompatibility. Focusing on the time interval 2015–2020, the production of 3D scaffolds of alginate, chitosan and agarose, for skin and bone regeneration, has mainly been investigated. Traditional techniques are critically reviewed to understand their limitations and how supercritical CO2-assisted processes could overcome these drawbacks. In particular, even if freeze-drying represents the most widespread drying technique used to produce polysaccharide-based cryogels, supercritical CO2-assisted drying effectively allows preservation of the nanoporous aerogel structure and removes the organic solvent used for gel preparation. These characteristics are essential for cell adhesion and proliferation.
Agarose-based gels were produced either by freeze-drying or by supercritical drying for crystal violet (CV) removal from aqueous solutions. The microporosity features of these structures highly affected the final adsorption properties. In particular, agarose cryogels were characterized by a macroporous and irregular morphology, with a low value of specific surface area (11 ± 6 m2/g) with respect to the nanoporous agarose aerogels (154 ± 12 m2/g). To test the efficacy of CV removal, two different types of adsorption test were performed, i.e., batch-mode and multi-step mode. Operating in the multi-step mode, the adsorption performance was larger both for cryogels and aerogels, since this adsorption method allowed a more effective contact between CV and agarose adsorbent. In particular, using 300 mg of cryogels, a removal efficiency of 74% was achieved; using the same quantity of aerogels, 96% of removal efficiency was reached after eight steps of adsorption. Desorption of CV from aerogels was realized using ascorbic acid and, after regeneration, 93% of removal efficiency was preserved, even after three cycles in multi-step filtration mode.
This work proposes an improvement of the traditional electrospraying process, in which supercritical carbon dioxide (SC-CO2) is used to produce poly(lactic-co-glycolic acid) (PLGA) nanoparticles. The experiments were performed at different PLGA concentrations (1, 3 and 5% w/w), applied voltages (10 and 30 kV) and operating pressures (80, 120 and 140 bar). It was found that working at 140 bar and 30 kV, spherical nanoparticles, with mean diameters of 101 ± 13 nm and 151 ± 45 nm, were obtained, when solutions at 1% w/w and 3% w/w PLGA were electrosprayed, respectively. Increasing PLGA concentration up to 5% w/w, a mixture of fibers and particles was observed, indicating the transition to the electrospinning regime.
Supercritical CO2 (SC-CO2)-assisted electrospray has been successfully performed to obtain a sustained release of ceftriaxone sodium (CFX) from polylactic acid (PLA) nanoparticles. PLA nanoparticles ranged from 270 ± 70 to 310 ± 80 nm, when produced at 140 bar. CFX release in a phosphate-buffered solution ranged from about 5 min, when the pure antibiotic was tested, to a maximum of 1200 min when 140 bar and 4 wt% of PLA + CFX nanoparticles was used: operating at these process conditions, an increase of 240 times of the release time was observed and no interactions were produced between PLA and the antibiotic. The release curves were explained hypothesizing a two-step mass transfer mechanism consisting of polymer swelling and PLA ester bond cleavage.